The Pill Sam Altman Takes to Prolong His Life
He has two choices: the waiting game, or the bold move.
As the CEO of ChatGPT creator OpenAI, Sam Altman has become a household name, especially during the recent OpenAI boardroom upheaval. But fewer know that besides AI, Altman has another equally fervent passion.
Earlier this year, Altman invested a substantial $180 million of his own money in Retro Biosciences, a company doing anti-aging cell regeneration. Further, the 38 years old has been taking a pill to slow down aging and extend his own life.
Altman is just one of many Silicon Valley entrepreneurs making a foray into life-extending ventures. The enthusiasm is at least in part fueled by an ambitious outlook advocated by leading anti-aging scientists.
We used to think that with a combination of good genes and a healthy lifestyle, we could have close to or, in rare cases, more than 100 years’ life. However, some scientists believe our lifespan has significant room for growth. With advances in science and modern medicine, many can live to 130, 140, or even 150 years.
The bold claim is not without justification. I recently wrote an article about it. At this very moment, extensive research targeting various aspects of the aging such as genomic instability, mitochondrial…
